Latest Articles

Subject

Article
Early CNS neurodegeneration in radiologically isolated syndrome
Christina J. Azevedo, Eve Overton, Sankalpa Khadka, et al.

April 09, 2015
Editor's Corner
Identifying targets for diagnosis, prognosis, and treatment
Josep Dalmau

April 02, 2015
Article
The growing spectrum of antibody-associated inflammatory brain diseases in children
Sandra Bigi, Manisha Hladio, Marinka Twilt, et al.

April 02, 2015
Article
Clinical course and treatment of anti-HMGCR antibody–associated necrotizing autoimmune myopathy
Sudarshini Ramanathan, Daman Langguth, Todd A. Hardy, et al.

April 02, 2015
Clinical/Scientific Notes
Glial Cells Express Nuclear Nrf2 After Fumarate Treatment for Multiple Sclerosis and Psoriasis
Imke Metz, Sarah Traffehn, Katrin Straßburger-Krogias, et al.

April 02, 2015
Correction
Fatal acute liver failure with hepatitis B virus infection during natalizumab treatment in multiple sclerosis
March 19, 2015
Article
P2Y12 expression and function in alternatively activated human microglia
Craig S. Moore, Ariel R. Ase, Angham Kinsara, et al.

March 19, 2015
Article
MOG cell-based assay detects non-MS patients with inflammatory neurologic disease
Patrick Waters, Mark Woodhall, Kevin C. O'Connor, et al.

March 19, 2015
Clinical/Scientific Notes
A 41-year-old woman with acute weakness and encephalopathy associated with MOG antibodies
Katrina A. Morris, Paddy Waters, Mark R. Woodhall, et al.

March 19, 2015
Editorial
Is intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS?
Martin S. Weber

March 12, 2015

Pages